Biotech & Medtech
Biotech & Medtech news — Sunday 18 October 2026
5 stories from 1 sources, every one in English. Each links to its publisher.
-
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
MedCity News
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate…
-
Allswell Raises $7M to Grow LGBTQ+ Behavioral Health Platform
MedCity News
Allswell’s seed round was led by Rethink Impact, and included participation from Magnify Ventures, Ulu Ventures and Hopelab Ventures, joining existing investors Techstars and Amboy Street Ventures. The post Allswell Raises $7M to Grow…
-
The Antibiotics Exist —The System Cannot Deliver Them
MedCity News
This is not a discovery problem. It is a market entry and access problem, and it is far more tractable than the pipeline crisis we spend most of our attention on. The post The Antibiotics Exist —The System Cannot Deliver Them appeared…
-
Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment
MedCity News
Health care routinely recommends movement without providing assessment, dosage, progression, and follow-up that turn good advice into usable care. The post Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment…
-
UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform
MedCity News
UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform. The post UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform…